Novo Nordisk (NYSE: NVO) said Thursday that its oral Wegovy pill demonstrated greater weight loss and fewer side effects compared ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE